Unibio USA ApS: Financial statements 2024
CVR: 38179845
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Unibio USA ApS (CVR 38179845) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK -26,000 compared with DKK -17,000 the year before. Equity in the 2024 report amounted to DKK 45,000. The solvency ratio was 72.6%.
- Profit/Loss
- DKK -26,000
- Equity
- DKK 45,000
- Total Assets
- DKK 62,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | -26K | 45K | - |
| 2023 | - | - | -17K | 71K | - |
| 2022 | - | -18K | -34K | 88K | 0 |
| 2021 | - | -15K | -12K | 72K | 0 |
| 2020 | - | -14K | -11K | 8K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Unibio USA ApS has published its annual report for 2023. The net result was DKK -17,000.
As of January 24, 2024, Søren Olrik Eklund is registered as director of Unibio USA ApS.
As of January 24, 2024, David Richard Henstrom is registered as adm. dir. of Unibio USA ApS.
As of January 24, 2024, Jakob Brix Christensen has stepped down as director of Unibio USA ApS.
As of January 23, 2024, Søren Olrik Eklund has stepped down as adm. dir. of Unibio USA ApS.
About Unibio USA ApS
Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of David Richard Henstrom and Søren Olrik Eklund. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity in the 2025 report amounted to DKK 25,000.